Orthofix to Participate in Canaccord Genuity's 44th Annual Growth Conference

About this update from Orthofix Medical Inc.

Wednesday, August 14, 2024 at 2:30 pm Eastern Time LEWISVILLE, Texas --(BUSINESS WIRE)-- Orthofix Medical Inc . (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced that the Company will participate in Canaccord Genuity's 44th Annual Growth Conference in Boston . Management is scheduled to present on Wednesday, August 14, 2024 at 2:30 pm ET . Interested parties can access the live and archived webcast of the presentation on the Investors section of the Orthofix website at ir.orthofix.com . Internet Posting of Information Orthofix routinely posts information that may be important to investors in the “Investor Relations” section of its website at www.orthofix.com . The Company encourages investors and potential investors to consult the Orthofix website regularly for important information about Orthofix . About Orthofix Orthofix is a leading global spine and orthopedics company with a comprehensive portfolio of biologics, innovative spinal hardware, bone growth therapies, specialized orthopedic solutions, and a leading surgical navigation system. Its products are distributed in more than 60 countries worldwide. The Company is headquartered in Lewisville, Texas , where it conducts general business, product development, medical education and manufacturing, and has primary offices in Carlsbad, CA , with a focus on spine and biologics product innovation and surgeon education, and Verona, Italy , with an emphasis on product innovation, production, and medical education for orthopedics. The combined Company’s global R&D, commercial and manufacturing footprint also includes facilities and offices in Irvine, CA , Toronto, Canada , Sunnyvale, CA , Maidenhead, UK , Munich, Germany , Paris, France and São Paulo, Brazil . View source version on businesswire.com : https://www.businesswire.com/news/home/20240717588160/en/ Investor Relations Julie Dewey [email protected] 209.613.6945 Media Relations Denise Landry [email protected] 214.937.2529 Source: Orthofix Medical Inc.

View stock analysis, news, and events for Orthofix Medical Inc.